DEBINT4.GIF (10584 bytes)

DebRA International Completed Research Projects       

Establishment of a Genome Screening System Dedicated to EB Research and Identification of the Gene for Laryngo-Onycho-Cutaneous (LO C) Syndrome: a new form of EB

Name of Researchers: Dr W H Irwin McLean
Places of Research: Epithelial Genetic Group, Department of Dermatology & Cutaneous Biology, Jefferson Medical College, Philadelphia, USA.
Approved by DebRA
Medical & Scientific Advisory Panel:
16 September 1997
Budget approved by
DebRA central Committee:
Date Commenced 1 November 1997 for two years

 

SUMMARY OF RESEARCH BEING UNDERTAKEN

Aims of Research

i. To establish a genome-wide semi-automated genotyping strategy based on fluorescent multiplex PCR microsatellite markers for rapid genome analysis of "new" forms of EB and similar skin fragility diseases.

ii. To identify the genetic locus for LOC syndrome using the above strategy.

iii. Identify the gene containing pathogenic mutations responsible for LOC syndrome by (a) analysis of candidate genes and/or expressed sequence tags which map within the disease interval; or (b) positional cloning techniques.

Background

The Epithelial Genetics Group, a separate entity within the Department of Dermatology and Cutaneous Biology, Jefferson Medical College, was established at the end of 1996 with the recruitment of Irwin McLean and Frances Smith, formerly researchers in Prof. Birgit Lane's laboratory, Cell Structure Research Group, University of Dundee, UK. A principal aim of the Epithelial Genetics Group is to investigate Epidermolysis Bullosa and

related diseases causing fragility of the skin and other epithelial tissues. There exists a well established collaboration between Dr McLean and Dr John McGrath at St Thomas' Hospital, London in relation to the study of EB both in terms of ultrastructure and molecular genetics.

Over the past 5 years, members of this group (McLean, McGrath) have been involved in the study of EB and similar genetic skin disorders. This work arose out of the joint discovery by that group that mutations in human keratin genes are responsible for the autosomal dominant disorder, Epidermolyis Bullosa Simplex (EBS). Following this discovery, they went on to study the molecular pathogenesis of a number of other forms of EB and related keratinizing disorders. These findings have enabled facilitated greatly improved genetic counselling and pre-natal diagnosis of EB and similar diseases.

Summary

The proposed project will help diagnosis and classification of EB. This basic knowledge is necessary for the design of EB therapy.

There are now 10 genes known to cause EB. Identification of these genes has allowed better diagnosis for the various forms of EB. Also, carriers of the faulty gene can be identified in affected families and pre-natal testing can be offered couples carrying these gene defects. In this way, this distressing disorder can be prevented from occurring again in affected families. However, there are many forms of EB where the gene is still unknown and these families cannot be offered genetic counselling until the genes are found. Until recently, finding new genes has been very difficult and expensive and could take one or two years. However, recent advances in genetics have led to the development of a new system for finding genes in weeks instead of years and is much less expensive. This project seeks to set up a system dedicated to looking for EB genes. The researchers will first use the system to find the gene for LOC syndrome, a severe type of EB and then go on to look at other similar diseases. The system will be made freely available to other EB researchers around the world. In the long term, knowing what all the EB genes are will help us understand the function of the skin and design gene therapy for EB.


About DebRA | About EB | Management of EB | Research | News & Events | Resources |

DebRA House  13 Wellington Business Park, Dukes Ride, Crowthorne, Berkshire RG45 6LS
Telephone: +44 (0) 1344 771961  Fax: +44 (0) 1344 762661
DebRA is a registered charityRegistered in Austria ZVR No 932762489

© DebRA international all rights reserved 2002